During the past decade, Cottage Pulmonary Hypertension Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cottage Pulmonary Hypertension Center" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Cottage Pulmonary Hypertension Center" in a lesser frequency.

Most popular intervention types in "Cottage Pulmonary Hypertension Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Beraprost Sodium 314d Modified Release Tablets" (1 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cottage Pulmonary Hypertension Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cottage Pulmonary Hypertension Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cottage Pulmonary Hypertension Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cottage Pulmonary Hypertension Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".